en
svPress releases
Regulatory press release 2020-07-31
Xspray Pharma publishes Interim Report Q2, January – June 2020
Press release 2020-07-03
First study group has been dosed in Xspray Pharma’s ongoing pivotal registration studies with HyNap-Dasa
Press release 2020-06-25
Xspray – Virtual Capital Markets Day today at 14.00 CET
Press release 2020-06-18
Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET
Regulatory press release 2020-05-29
Xspray Pharma initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States
Regulatory press release 2020-05-14
Bulletin from the annual general meeting of Xspray Pharma AB (publ)
Press release 2020-05-14
Xspray Pharma publishes Interim report Q1, January – March 2020
Regulatory press release 2020-04-15
Xspray Pharma provides an update on how the Covid-19 pandemic affects the company’s planned clinical studies
Regulatory press release 2020-04-14
XSpray: Notice of annual general meeting of Xspray Pharma AB (publ)
Press release 2020-03-27